Join Now

Yearly Archives: 2024

SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY

By Natalie Themm | Published June 12, 2024

SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY

Posted in BioUtah News | Tagged | Comments Off on SINTX TECHNOLOGIES RECEIVES ADDITIONAL SBIR CONTRACT FOR 3D PRINTING TECHNOLOGY

NUSANO NAMES D. SCOTT HOLBROOK AS CHAIRMAN OF ITS BOARD

By Natalie Themm | Published June 12, 2024

VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced industry veteran D. Scott Holbrook as chairman of its board. Holbrook is the co-founder of Invivo Molecular Imaging, and currently serves as the general manager and chief strategy officer for Pharmalogic, a leading contract development […]

Posted in BioUtah News | Tagged | Comments Off on NUSANO NAMES D. SCOTT HOLBROOK AS CHAIRMAN OF ITS BOARD

Governor Cox Visits BD

By admin | Published June 6, 2024

SANDY, UTAH, June 6, 2024—Today Governor Spencer Cox visited BD’s Sandy campus to meet with company executives and participate in a town hall meeting with BD employees. Cox’s visit began by listening to a brief presentation about BD’s local and global impact to both patients and the Utah economy by Jeff Stevens, BD’s vice president/general […]

Posted in BioUtah News | Comments Off on Governor Cox Visits BD

Utah Gathers at BIO International 2024 in San Diego

By admin | Published June 6, 2024

BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in San Diego, CA. drew appproximately 19,000 attendees. The Utah delegation included BioUtah, Utah companies, the Governor’s Office of Economic Development, the Unversity of Utah’s […]

Posted in BioUtah News | Comments Off on Utah Gathers at BIO International 2024 in San Diego

A former legislator and a biotech executive join Tribune’s board of directors

By Natalie Themm | Published June 6, 2024

Rebecca Chavez-Houck and Chris Gibson bring unique perspectives to board that oversees the nonprofit news outlet, they said.

Posted in BioUtah News | Tagged | Comments Off on A former legislator and a biotech executive join Tribune’s board of directors

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

By Natalie Themm | Published June 6, 2024

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

Posted in BioUtah News | Tagged | Comments Off on Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

ELITechGroup achieves a new CE-IVDR Certification

By Natalie Themm | Published June 6, 2024

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories

Posted in BioUtah News | Tagged | Comments Off on ELITechGroup achieves a new CE-IVDR Certification

Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

By Natalie Themm | Published June 6, 2024

The Thermo Scientific™ Stellar™ mass spectrometer combines speed and sensitivity to advance precision medicine.

Posted in BioUtah News | Tagged | Comments Off on Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

Denali Therapeutics Announces FDA Has Selected DNL126 for MPS IIIA for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

By Natalie Themm | Published June 6, 2024

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological products for rare diseases

Posted in BioUtah News | Tagged | Comments Off on Denali Therapeutics Announces FDA Has Selected DNL126 for MPS IIIA for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies

FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

By Natalie Themm | Published June 6, 2024

FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

Posted in BioUtah News | Tagged | Comments Off on FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

TD Cowen 8th Annual Future of the Consumer Conference 2024

By Natalie Themm | Published June 6, 2024

Owlet presented at the TD Cowen 8th Annual Future of the Consumer Conference 2024.

Posted in BioUtah News | Tagged | Comments Off on TD Cowen 8th Annual Future of the Consumer Conference 2024

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

By Natalie Themm | Published June 6, 2024

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

Posted in BioUtah News | Tagged | Comments Off on Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

A Special Thanks To Our Legacy and Platinum Elite Members